Lakewood-Amedex Biotherapeutics completes key scale-up steps for lead antimicrobial gel
Compartilhar
Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) announced positive chemistry, manufacturing, and controls (CMC) data supporting the late-stage development of its lead antimicrobial candidate, Nu-3.
